Immunologic principles and immunotherapeutic approaches in ovarian cancer

Keith L Knutson, Tyler J. Curiel, Lupe Salazar, Mary L. Disis

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Ovarian cancer is an immunogenic tumor, and numerous antigens have been identified in recent years. Several of these antigens are important in regulating tumor growth and may be ideal targets for the development of immune-based strategies. In the absence of immunologic intervention, tumors evade the immune system by several mechanisms, most notably tolerance and immunosuppression. As understanding of the immune response improves, strategies are being designed to circumvent T-cell tolerance to self-antigens through modulation of APC function. In addition, techniques are being developed to identify reverse ovarian cancer-induced immune evasion tactics. The type of the immune-based therapy to apply varies with disease burden. It is hoped that discoveries at the bench along with lessons learned in prior clinical trials soon will allow clinicians to develop rationally based immunologic strategies to treat and prevent ovarian cancer.

Original languageEnglish (US)
Pages (from-to)1051-1073
Number of pages23
JournalHematology/Oncology Clinics of North America
Volume17
Issue number4
DOIs
StatePublished - Aug 2003
Externally publishedYes

Fingerprint

Ovarian Neoplasms
Immune Evasion
Autoantigens
Neoplasm Antigens
Immunosuppression
Immune System
Neoplasms
Clinical Trials
T-Lymphocytes
Antigens
Growth
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Immunologic principles and immunotherapeutic approaches in ovarian cancer. / Knutson, Keith L; Curiel, Tyler J.; Salazar, Lupe; Disis, Mary L.

In: Hematology/Oncology Clinics of North America, Vol. 17, No. 4, 08.2003, p. 1051-1073.

Research output: Contribution to journalArticle

Knutson, Keith L ; Curiel, Tyler J. ; Salazar, Lupe ; Disis, Mary L. / Immunologic principles and immunotherapeutic approaches in ovarian cancer. In: Hematology/Oncology Clinics of North America. 2003 ; Vol. 17, No. 4. pp. 1051-1073.
@article{e40b6f07a5d3422eba0c7fc72de9b91f,
title = "Immunologic principles and immunotherapeutic approaches in ovarian cancer",
abstract = "Ovarian cancer is an immunogenic tumor, and numerous antigens have been identified in recent years. Several of these antigens are important in regulating tumor growth and may be ideal targets for the development of immune-based strategies. In the absence of immunologic intervention, tumors evade the immune system by several mechanisms, most notably tolerance and immunosuppression. As understanding of the immune response improves, strategies are being designed to circumvent T-cell tolerance to self-antigens through modulation of APC function. In addition, techniques are being developed to identify reverse ovarian cancer-induced immune evasion tactics. The type of the immune-based therapy to apply varies with disease burden. It is hoped that discoveries at the bench along with lessons learned in prior clinical trials soon will allow clinicians to develop rationally based immunologic strategies to treat and prevent ovarian cancer.",
author = "Knutson, {Keith L} and Curiel, {Tyler J.} and Lupe Salazar and Disis, {Mary L.}",
year = "2003",
month = "8",
doi = "10.1016/S0889-8588(03)00064-9",
language = "English (US)",
volume = "17",
pages = "1051--1073",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Immunologic principles and immunotherapeutic approaches in ovarian cancer

AU - Knutson, Keith L

AU - Curiel, Tyler J.

AU - Salazar, Lupe

AU - Disis, Mary L.

PY - 2003/8

Y1 - 2003/8

N2 - Ovarian cancer is an immunogenic tumor, and numerous antigens have been identified in recent years. Several of these antigens are important in regulating tumor growth and may be ideal targets for the development of immune-based strategies. In the absence of immunologic intervention, tumors evade the immune system by several mechanisms, most notably tolerance and immunosuppression. As understanding of the immune response improves, strategies are being designed to circumvent T-cell tolerance to self-antigens through modulation of APC function. In addition, techniques are being developed to identify reverse ovarian cancer-induced immune evasion tactics. The type of the immune-based therapy to apply varies with disease burden. It is hoped that discoveries at the bench along with lessons learned in prior clinical trials soon will allow clinicians to develop rationally based immunologic strategies to treat and prevent ovarian cancer.

AB - Ovarian cancer is an immunogenic tumor, and numerous antigens have been identified in recent years. Several of these antigens are important in regulating tumor growth and may be ideal targets for the development of immune-based strategies. In the absence of immunologic intervention, tumors evade the immune system by several mechanisms, most notably tolerance and immunosuppression. As understanding of the immune response improves, strategies are being designed to circumvent T-cell tolerance to self-antigens through modulation of APC function. In addition, techniques are being developed to identify reverse ovarian cancer-induced immune evasion tactics. The type of the immune-based therapy to apply varies with disease burden. It is hoped that discoveries at the bench along with lessons learned in prior clinical trials soon will allow clinicians to develop rationally based immunologic strategies to treat and prevent ovarian cancer.

UR - http://www.scopus.com/inward/record.url?scp=0041431005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041431005&partnerID=8YFLogxK

U2 - 10.1016/S0889-8588(03)00064-9

DO - 10.1016/S0889-8588(03)00064-9

M3 - Article

C2 - 12959191

AN - SCOPUS:0041431005

VL - 17

SP - 1051

EP - 1073

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 4

ER -